A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4
65
about 3.1 years
18–65
40 sites in AL, AZ, CA +19
About this study
Researchers are testing whether a treatment with vedolizumab and tofacitinib is effective for adults with ulcerative colitis. The trial also explores the effect of vedolizumab alone after this combined treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Tofacitinib
- 2.Take Vedolizumab
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
tofacitinib, vedolizumab
oral (Oral Tablet), injection, intravenous
Secondary: Change in C-Reactive Protein Levels (CRP) From Baseline, Change in Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) Score From Baseline, Number of Participants With Adverse Events (AEs), Adverse Events of Special Interest (AESIs) and Serious Adverse Events (SAEs)
Gastroenterology